D-0037-2027 Class II Ongoing

Recalled by Apothecary Pharma LLC — Cary, NC

FDA drug recall D-0037-2027 was initiated by Apothecary Pharma LLC on Sep 24, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 1 vial.

Recall details

Product Type
Drugs
Report Date
Oct 14, 2026
Initiation Date
Sep 24, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1 vial

Product description

Apothecary NAD+ Injection 200 mg/mL, 6 mL Sterile Multi-Dose Vial, Rx Only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC, 27513, NDC 85091-011-06.

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

Nationwide within the United States

Code information

Lot #: AP-202647, BUD 13-Oct-2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0037-2027
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0037-2027. Report a data issue: hello@regdatalab.com.